Zacks.com on MSN1 个月
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term Outlook
GSK plc GSK reported fourth-quarter 2024 core ... Sales of Trelegy Ellipta and Flixotide/Flovent surged 17% and 47%, ...